Advertisement|Remove ads.

OpenAI on Monday said it has acquired healthcare startup Torch as the ChatGPT owner continues to push and expand its offerings in the healthcare sector.
The company did not disclose the deal value at which it is acquiring the startup. As part of the deal, Torch co-founders Ilya Abyzov and Eugene Huang will join OpenAI, it said in a post on X.
“We designed Torch to be a unified medical memory for AI, bringing every bit of data about you from hospitals, labs, wearables, and consumer testing companies into one place,” Ilya Abyzov said in a post on X.
OpenAI’s Healthcare Push
OpenAI last week launched its ChatGPT Health to bring user health information and ChatGPT’s intelligence together that will give tailored responses to users to help them navigate their healthcare better.
OpenAI said that ChatGPT Health has been developed in close collaboration with physicians around the world to provide clear and useful health information and it worked with more than 260 physicians for the platform over two years.
Anthropic on Sunday launched Claude for healthcare which is a complementary set of tools and resources that allow healthcare providers, payers, and consumers to use Claude for medical purposes through Health Insurance Portability and Accountability Act (HIPAA)-ready products.
With Claude, Anthropic aims to attract healthcare startups by supporting them in building new products, and for large enterprises looking to integrate AI more deeply into their operations.
Nvidia has been in the healthcare sector as it offers high-performance computing platforms and hardware that helps pharma firms in their deployment of AI models for medical imaging. Its Clara platform is a family of open-source AI foundation models, tools, and recipes for biomedical research.
Google has also stepped up its efforts in the sector with the help of Google Health and Google DeepMind that are focused on applying advanced machine learning to detect early cancer, drug development and environmental research. Last year, Google also unveiled an AI co-scientist tool, developed by DeepMind.
Retail sentiment around OpenAI trended in ‘bullish’ territory amid ‘normal’ message volume.